bioMerieux, Inc.

Sam Shull

bioMérieux has been a global leader in in vitro diagnostics for over 50 years. The NephroCheck Test System assesses the risk of Acute Kidney before damage occurs in patients who currently have or have had within the past 24 hours acute cardiovascular and or respiratory compromise. For more information, visit or